Clinical Trial Update: Monitoring Minimal Residual Disease in Gastric Cancer by Liquid Biopsy Study Description

View source ↗

Summary

Clinical trial evaluating using liquid biopsy to monitor minimal residual disease in gastric cancer; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Snippet

Sponsor: University Medical Center Ho Chi Minh City (UMC) | Conditions: Gastric Cancer, ctDNA | Status: ACTIVE_NOT_RECRUITING